XB130 has been suggested to play significant roles in cancer progression through PI3K/Akt signaling pathway, leading to an increase in tumorigenic properties, including cell growth, migration, invasion and epithelial–mesenchymal transition (EMT) process [17, 31, 35–37]. The gene discussed is AKT1; the disease is cancer.